CRISIL Reaffirms Credit Ratings for Gufic Biosciences' Enhanced Bank Facilities
Gufic Biosciences Ltd 路 Others (Uncategorized) 路 09 Sept 2026, 12:21 am
CRISIL Reaffirms Credit Ratings for Gufic Biosciences' Enhanced Bank Facilities CRISIL Ratings has reaffirmed its credit ratings on the bank facilities of Gufic Biosciences Limited. The company's total rated bank loan facilities have been enhanced to Rs. 516 Crore from Rs. 425 Crore. CRISIL reaffirmed the long-term rating at 'CRISIL A-/Stable' and the short-term rating at 'CRISIL A2+', reflecting sustained operational stability and creditworthiness across its enhanced borrowing limits.
Original exchange filing (PDF)
More announcements from Gufic Biosciences Ltd
- Intimation of Audio Recording of Earnings Conference Call held on November 16, 2026 at 04:30 p.m. is attached herewith 路 17 Nov 2026
- Investor Presentation is attached herewith 路 15 Nov 2026
- Intimation for appointment of Additional Director (Non-Executive Independent Director) of the Company is attached herewith. 路 15 Nov 2026
- Gufic Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2026 is attached herewith 路 15 Nov 2026
- Outcome of the Board of Directors Meeting held on Saturday, November 14, 2026 is attached herewith. 路 15 Nov 2026
- Intimation of Environmental, Social and Governance (''ESG'') Rating is attached herewith 路 13 Nov 2026
- Intimation of Earnings Conference Call scheduled to be held on November 16, 2026 is attached herewith 路 16 Nov 2026
